Abstract
Various features, components, and functions of the immune system present daily variations. Immunocompetent cell counts and cytokine levels present variations according to the time of day and the sleep-wake cycle. Moreover, different immune cell types, such as macrophages, natural killer cells, and lymphocytes, contain a circadian molecular clockwork. The biological clocks intrinsic to immune cells and lymphoid organs, together with inputs from the central pacemaker of the suprachiasmatic nuclei via humoral and neural pathways, regulate the function of cells of the immune system, including their response to signals and their effector functions. Consequences of this include, for example, the daily variation in the response to an immune challenge (e.g., bacterial endotoxin injection) and the circadian control of allergic reactions. The circadian-immune connection is bidirectional, because in addition to this circadian control of immune functions, immune challenges and immune mediators (e.g., cytokines) were shown to have strong effects on circadian rhythms at the molecular, cellular, and behavioral levels. This tight crosstalk between the circadian and immune systems has wide-ranging implications for disease, as shown by the higher incidence of cancer and the exacerbation of autoimmune symptoms upon circadian disruption.
| Original language | English |
|---|---|
| Journal | Chronobiology International |
| Volume | 30 |
| Issue number | 7 |
| Pages (from-to) | 870-888 |
| Number of pages | 19 |
| ISSN | 0742-0528 |
| DOIs | |
| Publication status | Published - 01.08.2013 |
Funding
This work was supported by ‘‘Italian Ministry of Health’’ grant RC1203ME46 through Department of Medical Sciences, Division of Internal Medicine and Chronobiology Unit, IRCCS Scientific Institute and Regional General Hospital ‘‘Casa Sollievo della Sofferenza,’’ Opera di Padre Pio da Pietrelcina, San Giovanni Rotondo (FG), Italy; the Canadian Institutes for Health Research; the Natural Science and Engineering Research Council and the Fonds de Recherche du Québec—Santé; and by the National Institutes of Health grants R37 AA08757, R01 AA015718, and R01 HL088041.